Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Magnetic Resonance Spectroscopy 84 Specimen Handling 83 Cyclophosphamide 75 pembrolizumab 64 Radiotherapy 54 Nivolumab 52 fludarabine 44 Cisplatin 40 Biopsy 40 Carboplatin 39 Standard of Care 38 Bevacizumab 32 Dexamethasone 31 Rituximab 29 Gemcitabine 29 venetoclax 27 Surveys and Questionnaires 27 Radiosurgery 27 Radiation 27 Temozolomide 26 Practice Guidelines as Topic 26 Paclitaxel 25 Doxorubicin 25 Blood Specimen Collection 25 Cytarabine 24 fludarabine phosphate 23 Interviews as Topic 22 atezolizumab 21 Injections 20 Capecitabine 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Triiodothyronine × 30 days × Clear all

NCT07346157 2026-06-01

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡